February 14, 2018 | Canadian medical cannabis producer and distributor WeedMD has announced it has joined the Cannabis Database Project led by Israel’s prestigious Technion-Israel Institute of Technology. The two groups “will be collaborating in the research of cannabinoid and terpenoid profiles of 25 of WeedMD’s cannabis strains,” a statement said. The Technion has already profiled more than 150 strains, including all of the strains currently available under Israel’s regulated medical cannabis market. The data collected from this research will be added to an international database that associates pharmacological effects used to determine effective cannabis treatments for clinical purposes in Israel. The Cannabis Database Project aims to produce an integrated database with both clinical data on cannabis patients as and data on cannabis usage history for patients in Israel and abroad. Data from growers, HMOs, and other sources will be used for analyses aimed to identify specific treatments and organize them on a website for patients and doctors. “WeedMD is in a unique position to contribute data for our research studies and we’re proud to welcome them to our Cannabis Research Project,” said Dr. David Meiri, Head of the Laboratory of Cancer Biology and Cannabinoid Research at Technion-Israel Institute of Technology, who noted that members of the WeedMD team were recently hosted in Israel for important discussions on knowledge transfer and the collaboration.